Relative Bioavailability Study to Investigate a Potential Interaction Between DTG DT and F/TAF TOS.
Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This relative bioavailability (RBA) study will be conducted to investigate whether there is a
potential pharmacokinetic effect when paediatric DTG and F/TAF are taken together as
dispersible formulations. This study will be performed in healthy volunteers instead of
HIV-infected patients.